Aardvark Therapeutics, Inc. Common Stock Financial Flexibility Index
Aardvark Therapeutics, Inc. Common Stock financial flexibility index. Aardvark Therapeutics, Inc. Common Stock (AARD) has a Financial Flexibility Index of -1.71x as of September 2025. Free cash flow of $-18.51 Million (operating CF $-18.52 Million minus capex $4.00K) represents -2% of total liabilities ($10.85 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Aardvark Therapeutics, Inc. Common Stock (2022–2024)
Financial flexibility index of Aardvark Therapeutics, Inc. Common Stock from 2022 to 2024. Historical Financial Flexibility Index trend for Aardvark Therapeutics, Inc. Common Stock across 3 annual periods. Explore AARD operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Aardvark Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2022–2024)
Aardvark Therapeutics, Inc. Common Stock financial flexibility index by year from 2022 to 2024. Year-by-year free cash flow to debt coverage for Aardvark Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see AARD cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.14x | $-17.98 Million | $-18.09 Million | $132.15 Million | ▼ -5.9% |
| 2023 | -0.13x | $-5.82 Million | $-5.82 Million | $45.34 Million | ▲ +45.6% |
| 2022 | -0.24x | $-10.54 Million | $-10.54 Million | $44.68 Million | — |